跳至主要内容
临床试验/NCT02506829
NCT02506829已完成不适用

A Randomized Comparative Effectiveness Trial Of Financial Incentives Versus Usual Care For Smokers Hospitalized In The Veterans Affairs Hospital System

NYU Langone Health1 个研究点 分布在 1 个国家目标入组 182 人开始时间: 2015年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
182
试验地点
1
主要终点
Smoking abstinence assessed by self-reported and biochemically verified by salivary cotinine

研究概览

简要总结

The investigators plan to compare the impact of two approaches for smoking cessation on smoking abstinence, use of evidenced-based therapy, and quality of life among a diverse population of patients at the Manhattan campus of the VA New York Harbor Healthcare System, which serves a critical safety-net role for urban veterans. During hospitalization, all smokers will receive usual care. Patients will be randomized to one of two arms: financial incentives plus usual care vs. usual care alone, which includes referral to the state Quitline. All patients enrolled in the study will be offered nicotine replacement therapy. The investigators will conduct follow-up assessments at 2 weeks, 2 months, 6 months and 12 months after discharge. The primary study outcome is smoking abstinence at 6-month follow-up, verified by salivary/urinary cotinine.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •age ≥ 18 years,
  • •smoked tobacco during the prior 30 days,
  • •have an active U.S. phone number and address,
  • •can provide consent in English and
  • •are in at least the contemplative stage of change for quitting smoking, as assessed by a single measure, readiness to quit

排除标准

  • •use only smokeless tobacco,
  • •are pregnant or breastfeeding,
  • •are discharged to an institution (e.g., nursing home, long-term care facility),
  • •are unable to provide informed consent, or do not have cognitive ability to enroll or participate in the study

研究组 & 干预措施

Usual care

Active Comparator

Usual care in hospital, referral to a smoking cessation Quitline on discharge from hospital.

干预措施: Smoking cessation counseling (Quitline) (Behavioral)

Usual care

Active Comparator

Usual care in hospital, referral to a smoking cessation Quitline on discharge from hospital.

干预措施: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy) (Behavioral)

Financial Incentives

Experimental

Usual care in hospital, referral to a smoking cessation Quitline on discharge from hospital. Financial incentives for: a) speaking with a coach from the Smoker's Quitline ($50), b) completion of another community-based smoking-cessation program ($50), and/or c) use of pharmacotherapies for smoking cessation at 2 weeks ($50); and d) for smoking cessation, confirmed with the use of a cotinine test at 2 months ($150); and e) for smoking cessation, confirmed with the use of a cotinine test at 6 months after study enrollment ($250).

干预措施: Financial incentives (Behavioral)

Financial Incentives

Experimental

Usual care in hospital, referral to a smoking cessation Quitline on discharge from hospital. Financial incentives for: a) speaking with a coach from the Smoker's Quitline ($50), b) completion of another community-based smoking-cessation program ($50), and/or c) use of pharmacotherapies for smoking cessation at 2 weeks ($50); and d) for smoking cessation, confirmed with the use of a cotinine test at 2 months ($150); and e) for smoking cessation, confirmed with the use of a cotinine test at 6 months after study enrollment ($250).

干预措施: Smoking cessation counseling (Quitline) (Behavioral)

Financial Incentives

Experimental

Usual care in hospital, referral to a smoking cessation Quitline on discharge from hospital. Financial incentives for: a) speaking with a coach from the Smoker's Quitline ($50), b) completion of another community-based smoking-cessation program ($50), and/or c) use of pharmacotherapies for smoking cessation at 2 weeks ($50); and d) for smoking cessation, confirmed with the use of a cotinine test at 2 months ($150); and e) for smoking cessation, confirmed with the use of a cotinine test at 6 months after study enrollment ($250).

干预措施: Smoking cessation pharmacotherapy (e.g, nicotine replacement therapy) (Behavioral)

结局指标

主要结局

Smoking abstinence assessed by self-reported and biochemically verified by salivary cotinine

时间窗: 6 months

Assessed by self-report questionnaire, and biochemically verified by salivary cotinine

次要结局

  • Long term return on investment of using financial incentives to promote smoking cessation (Cost analysis)(3 years)
  • Smoking abstinence assessed by self-report(6 months)
  • Short term return on investment of using financial incentives to promote smoking cessation (Cost analysis)(12 months)
  • Use of evidence based treatment (e.g. counseling and smoking cessation medications) assessed by discharge prescriptions, Quitline records, receipts, letters and/or self-report(2 weeks and 2 months)
  • Quality of life as measured by the EQ5-D and VR-12(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验